Anti-osteoporosis agent-2 (Compound 10) serves as an inhibitor of osteoclast differentiation induced by RANKL [1].

抗骨质疏松剂-2（化合物10；浓度0.03-10 μM；作用时间4-5天）能有效抑制RANKL诱导的BMM成骨细胞分化，其半抑制浓度（IC50）为0.83 μM [1]。